Colossal Biosciences CEO Dissects the $10B Startup’s Effort to Bring Back Extinct Animals: Interview
Bringing the woolly mammoth back to life is no easy task. But for Ben Lamm, CEO of Colossal Biosciences, the stress of the ...
Smithsonian Magazine on MSN17d
Biotech Company Creates ‘Woolly Mouse’ as a Step in Its Quest to Resurrect Woolly Mammoths Through Gene EditingColossal Biosciences leaders say the fluffy, golden-haired mice help validate their technique to “de-extinct” species, but ...
Colossal Biosciences has been quietly approaching zoos and safari parks across North America and Europe, as the company ...
Colossal Biosciences has been quietly approaching zoos and safari parks across North America and Europe, as the company ...
Featuring Ben Lamm, Founder and CEO, Colossal Biosciences and Joe Manganiello, Actor, Producer. Moderated by Kc ...
Fresh from raising $200 million, Colossal Biosciences announced it has genetically engineered the Colossal Woolly Mouse, with a warm coat taken from the genes of the extinct woolly mammoth.
How can a startup provide a return on investment from bringing the woolly mammoth back from the dead? Ben Lamm, the CEO and cofounder of Colossal Biosciences, the startup developing "de-extinction ...
A while back, Thomas Tull, billionaire Hollywood mogul turned venture capitalist, invited a group of friends to a rodeo in ...
Colossal Biosciences genetically engineered a ‘woolly mouse’ with mammoth traits. The milestone could inform human gene therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback